===============================================================================

                                                /------------------------------/
                                                /        OMB APPROVAL          /
                                                /------------------------------/
                                                / OMB Number:        3235-0287 /
                                                / Expires: January 31, 2005    /
                                                / Estimated average burden     /
                                                / hours per response...... 0.5 /
                                                /------------------------------/
+--------+
| FORM 4 |               UNITED STATES SECURITIES AND EXCHANGE COMMISSION
+--------+                          Washington, D.C. 20549
[_] Check this box if
    no longer subject         STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
    to Section 16.
    Form 4 or Form 5       Filed pursuant to Section 16(a) of the Securities
    obligations may           Exchange Act of 1934, Section 17(a) of the
    continue. See            Public Utility Holding Company Act of 1935 or
    Instruction 1(b).      Section 30(f) of the Investment Company Act of 1940

(Print or Type Responses)
- --------------------------------------------------------------------------------
1.  Name and Address of Reporting Person*

    Elingburg,                      Wesley                       R.
- --------------------------------------------------------------------------------
     (Last)                        (First)                    (Middle)

c/o Laboratory Corporation of America
420 South Spring Street
- --------------------------------------------------------------------------------
                                    (Street)

Burlington,                         North Carolina                   27215
- --------------------------------------------------------------------------------
  (City)                               (State)                       (Zip)

2.  Issuer Name and Ticker or Trading Symbol

    Labortory Corporation of America Holdings ("LH")
    ----------------------------------------------------------------------------

3.  I.R.S. Identification Number of Reporting Person, if an entity
    (voluntary)
                --------------

4.  Statement for Month/Year  February 2002
                              --------------------------------------------------

5.  If Amendment, Date of Original (Month/Year)
                                               ---------------------------------

6.  Relationship of Reporting Person(s) to Issuer (Check all applicable)
    ___ Director     X  Officer             ___ 10% Owner    ___ Other
                    --- (give title below)                       (specify below)

Executive Vice President, Chief Financial Officer and Treasurer
- --------------------------------------------------------------------------------

7.  Individual or Joint/Group Filing (Check Applicable Line)
     X    Form filed by One Reporting Person
    ---

    ____ Form filed by More than One Reporting Person
- -------------------------------------------------------------------------------

Table I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- --------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------ 1. Title 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature of of action action or Disposed of (D) Securities ship Indirect Security Date Code (Instr. 3, 4 and 5) Beneficially Form: Benefically (Instr. 3) (Month/ (Instr. 8) Owned at Direct Ownership Day/ ------------------------------------------- End of (D) or Year) Month Indirect Code V Amount (A)or (D) Price (Instr. 3 and 4) (I) (Instr. 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock (1) 02/15/02 M 8,600 A $ 20.625 D - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock (1) 02/15/02 S 3,600 D $ 87.00 D - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock (1) 02/15/02 S 100 D $ 87.01 D - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock (1) 02/15/02 S 1,900 D $ 86.85 D - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock (1) 02/15/02 S 3,000 D $ 87.08 136,424.0924 D - ------------------------------------------------------------------------------------------------------------------------------------
(1) Transactions indicated were pursuant to a plan in compliance with Rule 10b5 -1 under the Securities Exchange Act of 1934. Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
- ------------------------------------------------------------------------------------------------------------------------------ 1. Title of Derivative 2. Conversion 3. Transaction 4. Transaction 5. Number of Security (Instr. 3) or Exercise Date Code Derivative Securities Price of (Month/Day/ (Instr. 8) Acquired (A) or Derivative Year) Disposed of (D) Security (Instr. 3, 4, and 5) -------------------------------------------------- Code V (A) (D) - ----------------------------------------------------------------------------------------------------------------------------- Employee Stock Option(1)(2) $20.625 02/15/02 M 8,600 - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------------- 6. Date Exer- 7. Title and Amount of 8. Price 9. Number 10. Owner- 11. Nature cisable and Underlying Securities of of Deriv- ship of In- Expiration (Instr. 3 and 4) Deriv- ative Form direct Date ative Securities of De- Bene- (Month/Day/ Security Beneficially rivative ficial Year) (Instr. Owned at End Securities Owner- 5) of Month Bene- ship (Instr. 4) ficially (Instr. Owned at 4) End of Month (Instr. 4) -------------------------------------------- Date Amount or Exer- Expiration Number of cisable Date Title Shares - -------------------------------------------------------------------------------------------------------------------------------- Common (3) 02/09/10 Stock 8,600 8,600 D - -------------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses: (1) Common stock purchase option granted under the Amended and Restated 1999 Stock Incentive Plan. (2) Transaction indicated was pursuant to a plan in compliance with Rule 10b5-1 under the Securities Exchange Act of 1934. (3) Total option to purchase 25,800 shares vests in three equal installments on February 9, 2001, February 9, 2002, and February 9, 2003. /s/ Bradford T. Smith March 11, 2002 --------------------------------------- -------------- **Signature of Reporting Person Date Bradford T. Smith, Attorney-In-Fact for Wesley R. Elingburg Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If this form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure.